CYP2C19 and breast cancer: Linear regression analysis of transcriptomics data derived from the The Cancer Genome Atlas (TCGA) [25] showed a positive correlation between FABP4, FABP5, and CYP2C19 gene expression in TNBC and ER+/PR+BC (Figure 1a).